These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 7766610)
21. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site. Li L; Jiang S; Li X; Liu Y; Su J; Chen J Eur J Med Chem; 2018 May; 151():482-494. PubMed ID: 29649743 [TBL] [Abstract][Full Text] [Related]
23. The mechanism of action of colchicine. Colchicine binding properties of sea urchin sperm tail outer doublet tubulin. Wilson L; Meza I J Cell Biol; 1973 Sep; 58(3):709-19. PubMed ID: 4747924 [TBL] [Abstract][Full Text] [Related]
24. Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains. Naaz F; Haider MR; Shafi S; Yar MS Eur J Med Chem; 2019 Jun; 171():310-331. PubMed ID: 30953881 [TBL] [Abstract][Full Text] [Related]
25. Microtubules as drug receptors: pharmacological properties of microtubule protein. Wilson L Ann N Y Acad Sci; 1975 Jun; 253():213-31. PubMed ID: 1096718 [No Abstract] [Full Text] [Related]
26. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules. Himes RH Pharmacol Ther; 1991; 51(2):257-67. PubMed ID: 1784631 [TBL] [Abstract][Full Text] [Related]
31. Aging of tubulin at neutral pH: stabilization by colchicine and its analogues. Prakash V; Timasheff SN Arch Biochem Biophys; 1992 May; 295(1):146-52. PubMed ID: 1575511 [TBL] [Abstract][Full Text] [Related]
34. Interaction of bovine brain tubulin with the 4(1H)-pyrizinone derivative IKP104, an antimitotic drug with a complex set of effects on the conformational stability of the tubulin molecule. Luduena RF; Roach MC; Prasad V; Chaudhuri AR; Tomita I; Mizuhashi F; Murata K Biochemistry; 1995 Dec; 34(48):15751-9. PubMed ID: 7495806 [TBL] [Abstract][Full Text] [Related]
35. [Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine]. Tsvetkov FO; Kulikova AA; Devred F; Zerniĭ EIu; Lafitte D; Makarov AA Mol Biol (Mosk); 2011; 45(4):697-702. PubMed ID: 21954603 [TBL] [Abstract][Full Text] [Related]
36. Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents. Lampidis TJ; Kolonias D; Savaraj N; Rubin RW Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1256-60. PubMed ID: 1346930 [TBL] [Abstract][Full Text] [Related]
37. [Inhibitors of tubulin assembly: specially on rhizoxin-maytansine site ligands]. Iwasaki S Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1742-52. PubMed ID: 8210422 [No Abstract] [Full Text] [Related]
38. Distances between the paclitaxel, colchicine, and exchangeable GTP binding sites on tubulin. Han Y; Malak H; Chaudhary AG; Chordia MD; Kingston DG; Bane S Biochemistry; 1998 May; 37(19):6636-44. PubMed ID: 9578547 [TBL] [Abstract][Full Text] [Related]
39. QM and QM/MD simulations of the Vinca alkaloids docked to tubulin. Kelly EB; Tuszynski JA; Klobukowski M J Mol Graph Model; 2011 Sep; 30():54-66. PubMed ID: 21798777 [TBL] [Abstract][Full Text] [Related]
40. Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography. Cruz-Monserrate Z; Mullaney JT; Harran PG; Pettit GR; Hamel E Eur J Biochem; 2003 Sep; 270(18):3822-8. PubMed ID: 12950266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]